Hypermobile Ehlers-Danlos patients receive an average of 10 wrong diagnoses over 10+ years because their real condition isn't in most doctors' differential

Hypermobile Ehlers-Danlos Syndrome (hEDS) causes chronic pain, joint instability, fatigue, and autonomic dysfunction that mimics a half-dozen more common conditions. The average hEDS patient receives 10.45 alternative diagnoses -- including fibromyalgia, anxiety, depression, migraines, and POTS -- before anyone considers the actual connective tissue disorder. The average time to correct diagnosis is over 10 years, with some studies reporting delays of 15 to 20 years from symptom onset. During those lost years, patients are treated for conditions they don't have with medications that don't work, while the underlying joint hypermobility causes progressive damage that proper physical therapy and bracing could have mitigated. The real harm isn't just the delay. It's what happens during the delay. Patients with undiagnosed hEDS undergo surgeries that fail because the surgeon didn't account for fragile tissue. They're prescribed SSRIs for "anxiety" that's actually POTS-related tachycardia. They're told their pain is psychosomatic. A 2023 study in Genetics in Medicine Open found that 56% of hEDS patients received at least one misdiagnosis, and those who were misdiagnosed took an average of 19 years to reach the correct diagnosis compared to 8 years for those who weren't. That's 11 additional years of wrong treatment, unnecessary procedures, and being told nothing is wrong. This problem persists for a structural reason: hEDS has no genetic test. Unlike other forms of Ehlers-Danlos (vascular, classical), where a specific gene mutation confirms the diagnosis, hEDS is diagnosed by clinical criteria alone -- the 2017 international criteria that require documenting joint hypermobility, systemic features, and family history. Most primary care physicians and even many rheumatologists have never learned these criteria. Medical school curricula devote minimal time to connective tissue disorders. The Beighton score for hypermobility is rarely taught. And because hEDS symptoms overlap heavily with fibromyalgia, chronic fatigue syndrome, and functional neurological disorder, the path of least resistance for a busy clinician is to assign one of those labels and move on. Until medical education catches up, hEDS patients will continue to be gaslit by a system that doesn't know their disease exists.